EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring GBA1 gene in Parkinson's disease: Prevalence and variant spectrum from Asia minor

Merve Koç Yekedüz, Rezzak Yilmaz, Talha Abali, Sema Nur Kibrit, Ahmet Veli Karacan, Elif Yüsra Unutmaz, Gülnur Ayık, Dudu Genç-Batmaz, G Rana Dilek, Binnur Çelik, Emine Gemci, Turgut Şahin und 4 weitere

Neurological Sciences · 2025

DOI: 10.1007/s10072-025-08286-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, 2025. Verfasst von Merve Koç Yekedüz und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Metabolism, Ankara University School of Medicine, Ankara, Turkey. drmervekoc13@hotmail.com. Hauptthemen laut MEDLINE: Parkinson Disease, Glucosylceramidase, beta-Glucosidase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer, Social Science University of Ankara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The GBA1 gene has been established as a notable risk factor in Parkinson's disease (PD). While some population-specific variants were reported, many regions of the world remain underexplored. This study investigates the prevalence, types, and clinical associations of GBA1 variants in a large cohort of patients with PD (PwP) from Turkey.

Methods

A total of 716 individuals, including 513 PwP and 203 healthy controls (HC), were evaluated. Genetic analysis of GBA1 variants was performed using nextgeneration sequencing. Additionally, whole exome sequencing (WES) was conducted on participants with detected GBA1 variants. Clinical data, including motor, non-motor, and quality of life assessments, were collected. Enzyme and substrate levels were measured from dry blood spot samples.

Results

GBA1 variants were found in 13.2% of PD patients, significantly higher than in HC (6.4%), corresponding to an average 2.2-fold higher prevalence. The most frequent variants were p.T369M, p.L444P, and p.N370S. Additionally, 15 variants not previously reported in PD were detected. Patients with pathogenic variants had an earlier age of onset including a higher levodopa-equivalent daily dose and motor complications. Enzyme and substrate levels did not differ significantly between the groups. In one patient, WES data showed a CTSB variant which was reported to modify the effects of GBA1 .

Conclusion

This is the largest study revealing prevalence of GBA1 variants among PwP in Turkey, with significant clinical implications. The findings enrich the literature by expanding the previously unknown landscape of GBA1 variants in this region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseGlucosylceramidasebeta-GlucosidaseHumansMaleFemaleMiddle AgedAgedPrevalenceTurkeyGenetic Predisposition to DiseaseAdultCohort Studies

Stichwörter der Autor:innen

GBA1Beta-glucocerebrosidaseParkinson's diseaseWhole exome sequencing

Substanzen

GBA protein, humanGlucosylceramidasebeta-Glucosidase

Autor:innen und Institutionen

  • Department of Pediatric Metabolism, Ankara University School of Medicine, Ankara, Turkey. drmervekoc13@hotmail.com.
  • Department of Anesthesiology, Harvard Medical School, Boston Children's Hospital, Critical Care and Pain Medicine, Boston, MA, USA. drmervekoc13@hotmail.com.
  • Ankara University Brain Research Center, Ankara, Turkey. rezzak.yilmaz@ankara.edu.tr.
  • Department of Neurology, Ankara University School of Medicine, Ankara, Turkey. rezzak.yilmaz@ankara.edu.tr.
  • Ankara University School of Medicine, Ankara, Turkey.
  • Department of Neurology, Ankara University School of Medicine, Ankara, Turkey.

Förderung

  • Pfizer
  • Social Science University of Ankara

Zitieren

APA

Koç Yekedüz, M., Yilmaz, R., Abali, T., Kibrit, S. N., Karacan, A. V., Unutmaz, E. Y., Ayık, G., Genç-Batmaz, D., Dilek, G. R., Çelik, B., Gemci, E., Şahin, T., Yalcin, A., Ceylaner, S., Akbostancı, M. C., & Eminoğlu, F. T. (2025). Exploring GBA1 gene in Parkinson's disease: Prevalence and variant spectrum from Asia minor. Neurological Sciences. https://doi.org/10.1007/s10072-025-08286-5

Vancouver

Koç Yekedüz M, Yilmaz R, Abali T, Kibrit SN, Karacan AV, Unutmaz EY, et al. Exploring GBA1 gene in Parkinson's disease: Prevalence and variant spectrum from Asia minor. Neurological Sciences. 2025. doi:10.1007/s10072-025-08286-5

BibTeX
@article{KoYekedz2025,
  author = {Koç Yekedüz, Merve and Yilmaz, Rezzak and Abali, Talha and Kibrit, Sema Nur and Karacan, Ahmet Veli and Unutmaz, Elif Yüsra and Ayık, Gülnur and Genç-Batmaz, Dudu and Dilek, G Rana and Çelik, Binnur and Gemci, Emine and Şahin, Turgut and Yalcin, Ahmet and Ceylaner, Serdar and Akbostancı, M Cenk and Eminoğlu, Fatma Tuba},
  title = {Exploring GBA1 gene in Parkinson's disease: Prevalence and variant spectrum from Asia minor},
  journal = {Neurological Sciences},
  year = {2025},
  doi = {10.1007/s10072-025-08286-5}
}
Kostenlos starten →